Raymond James & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Raymond James & Associates’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.14M	Sell	58,892 -3,992	-6%	-$334K	﹤0.01%	1777
2024 Q2	$5.18M	Sell	62,884 -7,309	-10%	-$608K	﹤0.01%	1548
2024 Q1	$6.13M	Buy	70,193 +14,982	+27%	+$1.34M	﹤0.01%	1444
2023 Q4	$5.32M	Buy	55,211 +201	+0.4%	+$17.8K	﹤0.01%	1495
2023 Q3	$4.87M	Sell	55,010 -357	-0.6%	-$31.8K	﹤0.01%	1471
2023 Q2	$4.8M	Buy	55,367 +5,126	+10%	+$482K	﹤0.01%	1506
2023 Q1	$4.89M	Sell	50,241 -10,168	-17%	-$1.05M	﹤0.01%	1476
2022 Q4	$6.25M	Buy	60,409 +2,517	+4%	+$236K	0.01%	1268
2022 Q3	$4.91M	Sell	57,892 -8,242	-12%	-$734K	0.01%	1390
2022 Q2	$5.48M	Buy	66,134 +19,378	+41%	+$1.54M	0.01%	1342
2022 Q1	$3.6M	Sell	46,756 -104,537	-69%	-$8.75M	﹤0.01%	1740
2021 Q4	$13.4M	Sell	151,293 -515	-0.3%	-$42.5K	0.01%	946
2021 Q3	$11.7M	Buy	151,808 +16,857	+12%	+$1.33M	0.01%	969
2021 Q2	$11.3M	Buy	134,951 +6,059	+5%	+$480K	0.01%	1010
2021 Q1	$9.73M	Sell	128,892 -74,211	-37%	-$6.06M	0.01%	1050
2020 Q4	$17.8M	Buy	203,103 +32,613	+19%	+$2.59M	0.02%	670
2020 Q3	$13M	Sell	170,490 -26,046	-13%	-$2.64M	0.02%	730
2020 Q2	$24.2M	Sell	196,536 -2,716	-1%	-$270K	0.03%	455
2020 Q1	$16.8M	Buy	199,252 +35,194	+21%	+$3.03M	0.03%	516
2019 Q4	$13.9M	Sell	164,058 -21,179	-11%	-$1.6M	0.02%	748
2019 Q3	$12.5M	Sell	185,237 -9,554	-5%	-$736K	0.02%	751
2019 Q2	$16.7M	Buy	194,791 +9,455	+5%	+$809K	0.02%	610
2019 Q1	$16.5M	Buy	185,336 +10,968	+6%	+$1.02M	0.03%	590
2018 Q4	$14.8M	Buy	174,368 +120	+0.1%	+$11.4K	0.03%	581
2018 Q3	$16.9M	Buy	174,248 +6,279	+4%	+$627K	0.03%	595
2018 Q2	$15.8M	Buy	167,969 +61,434	+58%	+$5.38M	0.03%	601
2018 Q1	$8.64M	Buy	106,535 +5,562	+6%	+$477K	0.02%	856
2017 Q4	$9M	Buy	100,973 +18,473	+22%	+$1.61M	0.02%	814
2017 Q3	$7.68M	Sell	82,500 -6,760	-8%	-$597K	0.02%	876
2017 Q2	$8.11M	Buy	89,260 +16,762	+23%	+$1.52M	0.02%	808
2017 Q1	$6.36M	Buy	72,498 +4,138	+6%	+$368K	0.01%	909
2016 Q4	$5.66M	Sell	68,360 -12,300	-15%	-$1.06M	0.01%	927
2016 Q3	$7.46M	Buy	80,660 +18,674	+30%	+$1.76M	0.02%	743
2016 Q2	$4.82M	Buy	61,986 +14,583	+31%	+$1.24M	0.02%	872
2016 Q1	$3.91M	Buy	47,403 +11,044	+30%	+$899K	0.01%	944
2015 Q4	$3.81M	Buy	36,359 +6,485	+22%	+$677K	0.01%	936
2015 Q3	$3.15M	Sell	29,874 -5,111	-15%	-$683K	0.01%	982
2015 Q2	$4.79M	Buy	34,985 +4,562	+15%	+$565K	0.02%	836
2015 Q1	$3.79M	Buy	30,423 +2,169	+8%	+$230K	0.02%	876
2014 Q4	$2.55M	Buy	28,254 +4,044	+17%	+$336K	0.01%	1019
2014 Q3	$1.75M	Buy	24,210 +2,893	+14%	+$190K	0.01%	1166
2014 Q2	$1.33M	Sell	21,317 -6,039	-22%	-$365K	0.01%	1322
2014 Q1	$1.87M	Sell	27,356 -4,020	-13%	-$296K	0.01%	1076
2013 Q4	$2.21M	Buy	31,376 +13,040	+71%	+$886K	0.02%	903
2013 Q3	$1.32M	Buy	18,336 +4,920	+37%	+$327K	0.01%	1095
2013 Q2	$748K	Buy	+13,416	New	+$836K	0.01%	1311